A MOUSE MODEL REVEALS VULNERABILITY OF IDH1-MUTATED GLIOMA TO FERROPTOSIS

被引：0

作者：

Mela, Angeliki ^{[1
]}

Dovas, Athanassios ^{[1
]}

Mahajan, Aayushi ^{[1
]}

Humala, Nelson ^{[1
]}

Trang Nguyen ^{[1
]}

Kanangat, Smriti ^{[1
]}

Upadhyayula, Pavan ^{[1
]}

Sprinzen, Lisa ^{[2
]}

Argenziano, Michael ^{[1
]}

Huang, Dennis ^{[3
]}

Guo, Jia ^{[4
]}

Casaccia, Patrizia ^{[3
]}

Siegelin, Markus ^{[1
]}

Stockwell, Brent ^{[4
]}

Bruce, Jeffrey ^{[1
]}

Canoll, Peter ^{[5
]}

机构：

[1] Columbia Univ, Med Ctr, New York, NY USA

[2] Univ Calif San Francisco, San Francisco, CA USA

[3] CUNY, ASRC, New York, NY USA

[4] Columbia Univ, New York, NY USA

[5] Columbia Univ, Irving Med Ctr, New York, NY USA

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EXTH-20

引用

页数：2

共 50 条

[1] Blockade of Glutathione Metabolism in IDH1-Mutated Glioma
Tang, Xiaoying
Fu, Xiao
Liu, Yang
Yu, Di
Cai, Sabrina J.
Yang, Chunzhang
MOLECULAR CANCER THERAPEUTICS, 2020, 19 (01) : 221 - 230
[2] TRIPTOLIDE, A NOVEL THERAPEUTIC AGENT FOR IDH1-MUTATED GLIOMA
Yu, Di
Liu, Yang
Xu, Guowang
Yang, Chunzhang
NEURO-ONCOLOGY, 2019, 21 : 82 - 82
[3] A perioperative study of Safusidenib in patients with IDH1-mutated glioma
Cain, Sarah A.
Topp, Monique
Rosenthal, Mark
Tobler, Robert
Freytag, Saskia
Best, Sarah A.
Whittle, James R.
Drummond, Katharine J.
FUTURE ONCOLOGY, 2024, 20 (33) : 2533 - 2545
[4] ACQUISITION OF WARBURG PHENOTYPE IN IDH1-MUTATED GLIOMA AS A MECHANISM OF MALIGNANT TRANSFORMATION
Rodado, Victor Ruiz
Seki, Tomohiro
Dowdy, Tyrone
Lita, Adrian
Celiku, Orieta
Yamamoto, Kazu
Saito, Keita
Saldana, Cavazos
Li, Aiguo
Cherukuri, Murali Krishna
Gilbert, Mark
Larion, Mioara
NEURO-ONCOLOGY, 2017, 19 : 131 - 132
[5] In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma
Khurshed, Mohammed
Molenaar, Remco J.
Lenting, Krissie
Leenders, William P.
van Noorden, Cornelis J. F.
ONCOTARGET, 2017, 8 (30) : 49165 - 49177
[6] Ivosidenib and Azacitidine in IDH1-Mutated AML
Gil-Sierra, Manuel D.
Pilar Briceno-Casado, M.
Sierra-Sanchez, Jesus F.
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (26): : 2535 - 2536
[7] An IDH1-mutated primary gliosarcoma: case report
Hsieh, Jason K.
Hong, Christopher S.
Manjila, Sunil
Cohen, Mark L.
Lo, Simon
Rogers, Lisa
Sloan, Andrew E.
JOURNAL OF NEUROSURGERY, 2017, 126 (02) : 476 - 480
[8] MAGNETIC RESONANCE OF 2-HYDROXYGLUTARATE IN IDH1-MUTATED LOW-GRADE GLIOMA
Jalbert, Llewellyn
Elkhaled, Adam
Phillips, Joanna J.
Yoshihara, Hikari A.
Parvataneni, Rupa
Srinivasan, Radhika
Bourne, Gabriela
Chang, Susan M.
Cha, Soonmee
Nelson, Sarah J.
NEURO-ONCOLOGY, 2011, 13 : 83 - 84
[9] mTORC2/Rac1 Pathway Predisposes Cancer Aggressiveness in IDH1-Mutated Glioma
Liu, Yang
Lu, Yanxin
Li, Aiguo
Celiku, Orieta
Han, Sue
Qian, Mingyu
Yang, Chunzhang
CANCERS, 2020, 12 (04)
[10] NRF2-GUIDED GLUTATHIONE SYNTHESIS IS AN ESSENTIAL METABOLIC PATHWAY IN IN IDH1-MUTATED GLIOMA
Liu, Yang
Yu, Di
Yang, Chunzhang
NEURO-ONCOLOGY, 2021, 23 : 33 - 33

← 1 2 3 4 5 →